We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
1676
DELISTED
Brookline Bancorp
BRKL
| $3.11M | ﹤0.01% |
284,714
+1,534
| +0.5% | +$14.6K |
|
1677
Hain Celestial
HAIN
$53.7M
| $3.11M | ﹤0.01% |
283,577
-1,273
| -0.4% | -$13.7K |
|
1678
Primoris Services
PRIM
$4.45B
| $3.1M | ﹤0.01% |
93,462
-264
| -0.3% | -$8.23K |
|
1679
Nu Skin
NUS
$267M
| $3.1M | ﹤0.01% |
159,587
-1,722
| -1% | -$31.8K |
|
1680
Huron Consulting
HURN
$2.42B
| $3.1M | ﹤0.01% |
30,134
+217
| +0.7% | +$22.3K |
|
|
SAVE
1681
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.09M | ﹤0.01% |
188,578
-11,112
| -6% | -$160K |
|
|
LSXMA
1682
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.09M | ﹤0.01% |
107,436
-738
| -0.7% | -$19.3K |
|
1683
iShares MSCI Germany ETF
EWG
$1.62B
| $3.08M | ﹤0.01% |
103,665
| – | – |
|
1684
Ichor Holdings
ICHR
$2.56B
| $3.07M | ﹤0.01% |
91,171
-426
| -0.5% | -$11.8K |
|
1685
CVR Energy
CVI
$3.13B
| $3.07M | ﹤0.01% |
101,184
-1,046
| -1% | -$33.1K |
|
1686
IDEAYA Biosciences
IDYA
$3.56B
| $3.06M | ﹤0.01% |
85,966
+7,172
| +9% | +$214K |
|
1687
Metallus
MTUS
$898M
| $3.05M | ﹤0.01% |
130,062
-2,308
| -2% | -$48.4K |
|
1688
Dime Commercial Bancshares
DCOM
$1.78B
| $3.03M | ﹤0.01% |
112,664
+5,457
| +5% | +$117K |
|
1689
WesBanco
WSBC
$4B
| $3.03M | ﹤0.01% |
96,647
-962
| -1% | -$25.8K |
|
1690
Fastly Inc
FSLY
$3.66B
| $3.03M | ﹤0.01% |
170,003
+1,345
| +0.8% | +$22.7K |
|
1691
Deluxe
DLX
$1.15B
| $3.03M | ﹤0.01% |
141,067
-416
| -0.3% | -$7.75K |
|
1692
Worthington Steel
WS
$1.95B
| $3.02M | ﹤0.01% |
+107,298
| New | +$2.94M |
|
1693
Celldex Therapeutics
CLDX
$3.28B
| $3.02M | ﹤0.01% |
76,022
-652
| -0.9% | -$19.2K |
|
1694
WIX.com
WIX
$2.52B
| $3.01M | ﹤0.01% |
24,468
+1,018
| +4% | +$98.2K |
|
|
CSR
1695
Centerspace
CSR
$952M
| $3.01M | ﹤0.01% |
51,691
+1,282
| +3% | +$70K |
|
1696
Iovance Biotherapeutics
IOVA
$2.87B
| $3M | ﹤0.01% |
368,456
+16,289
| +5% | +$85.2K |
|
1697
InvenTrust Properties
IVT
$2.59B
| $2.99M | ﹤0.01% |
118,060
-371
| -0.3% | -$9.25K |
|
1698
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $2.99M | ﹤0.01% |
93,374
-1,341
| -1% | -$38K |
|
1699
Cytek Biosciences
CTKB
$546M
| $2.99M | ﹤0.01% |
327,630
+5,638
| +2% | +$35.5K |
|
|
CHS
1700
DELISTED
Chicos FAS, Inc.
CHS
| $2.95M | ﹤0.01% |
388,959
-12,755
| -3% | -$95.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.